# Brady Corp: Form 10-Q for the period ended Oct 31, 2021

- Company: [Brady Corp](/companies/brc.md) (CIK 746598)
- Form: 10-Q
- Filed: 2021-11-18
- Accepted by EDGAR: Nov 18, 2021, 07:17 ET
- Period: 2021-10-31
- Accession: 0000746598-21-000198
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/746598/000074659821000198/brc-20211031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/746598/000074659821000198/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-10-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-08-01 to 2021-10-31 | $321.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-08-01 to 2021-10-31 | $166.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2021-08-01 to 2021-10-31 | $155.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2021-08-01 to 2021-10-31 | $13.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2021-08-01 to 2021-10-31 | $96.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-08-01 to 2021-10-31 | $44.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-08-01 to 2021-10-31 | $182.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-08-01 to 2021-10-31 | $9.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-08-01 to 2021-10-31 | $35.0m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2021-08-01 to 2021-10-31 | 52,436,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-08-01 to 2021-10-31 | $27.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-08-01 to 2021-10-31 | $11.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2021-08-01 to 2021-10-31 | $11.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2021-08-01 to 2021-10-31 | $18.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-10-31 | $157.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-10-31 | $505.1m | us-gaap:AssetsCurrent |
| Total assets | at 2021-10-31 | $1.41bn | us-gaap:Assets |
| Current liabilities | at 2021-10-31 | $266.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-10-31 | $446.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-10-31 | $963.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 26,779 characters.

#### Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative safety, identification and healthcare products. The WPS segment manufactures a broad range of stock and custom identification products and sells a broad range of resale products.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve the efficiency of our global operations, deliver a high level of customer service, develop and market innovative new products, and to advance our digital capabilities. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal 2022:

- Investing in organic growth by enhancing our research and development process and utilizing customer feedback to develop innovative new products.
- Investing in acquisitions that enhance our strategic position and accelerate long-term sales growth.
- Providing our customers with the highest level of customer service.
- Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.
- Driving operational excellence and executing sustainable efficiency gains within our global operations and within our selling, general and administrative structures and within our global operations including insourcing of critical products and manufacturing activities.
- Building on our culture of diversity, equity and inclusion to increase employee engagement and enhance recruitment and retention practices.

#### Impact of the COVID-19 Pandemic on Our Business

Brady Corporation is deemed an essential business under the majority of local government orders. Our products support first responders, healthcare workers, food processing companies, and many other critical industries. During the three months ended October 31, 2021, our facilities were operating globally with enhanced safety protocols designed to protect the health and safety of our employees.

The Company has experienced, and expects to continue to experience, increased input material cost inflation as a result of increased global demand, government-mandated actions in response to COVID-19 and labor shortages. The Company has taken action to mitigate inflation issues, which has offset some, but not all, of the impact of these trends. As a result, these trends negatively impacted the Company's gross profit margin and may continue to negatively impact profitability in fiscal 2022.

We believe we have the financial strength to continue to invest in organic sales growth opportunities, inorganic sales opportunities, sales and marketing, and research and development ("R&D"), while continuing to drive sustainable efficiencies and automation in our operations and selling, general and administrative ("SG&A") functions. At October 31, 2021, we had cash of $157.6 million, a credit facility with $130.1 million available for future borrowing, which can be increased up to $330.1 million at the Company's option and subject to certain conditions, for total available liquidity of approximately $487.7 million.

We believe that our financial resources including the remaining undrawn amount of the credit facility and our ability to increase that credit line as necessary and liquidity levels are sufficient to manage the continuing impact of the COVID-19 pandemic, including the spread of variants that could result in additional government actions around the world to contain the virus or prevent further spread which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2021, as well as the updates contained within this Quarterly Report on Form 10-Q, for further discussion of the possible impact of the COVID-19 pandemic on our business.

#### Results of Operations

The comparability of the operating results for the three months ended October 31, 2021, to the prior year has been impacted by the following acquisitions:

| Acquisitions | Segment | Date Completed |
| --- | --- | --- |
| Magicard Holdings Limited ("Magicard") | IDS | May 2021 |
| Nordic ID Oyj ("Nordic ID") | IDS | May 2021 |
| The Code Corporation ("Code") | IDS | June 2021 |

A comparison of results of operating income for the three months ended October 31, 2021 and 2020 is as follows:

*(Dollars in thousands)*

|  | Three months ended October 31, 2021 | % Sales | 2020 | % Sales |
| --- | ---: | ---: | ---: | ---: |
| **Net sales** | $321,475 |  | $277,227 |  |
| **Gross margin** | 154,988 | 48.2% | 135,428 | 48.9% |
| **Operating expenses:** |  |  |  |  |
| Research and development | 13,907 | 4.3% | 10,203 | 3.7% |
| Selling, general and administrative | 96,746 | 30.1% | 83,037 | 30.0% |
| Total operating expenses | 110,653 | 34.4% | 93,240 | 33.6% |
| **Operating income** | $44,335 | 13.8% | $42,188 | 15.2% |

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation and sales recorded from acquired companies prior to the first anniversary date of their acquisition. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended October 31, 2021, increased 16.0% to $321.5 million, compared to $277.2 million in the same period in the prior year. The increase consisted of organic sales growth of 7.0%, sales growth from acquisitions of 8.3% and an increase from foreign currency translation of 0.7%. Organic sales grew 13.2% in the IDS segment and declined 8.6% in the WPS segment during the three months ended October 31, 2021, compared to the same period in the prior year.

The most significant impact on organic sales due to the COVID-19 pandemic began in the second half of fiscal 2020 when varied government responses to the pandemic impacted a large demographic of our customers and the overall global economy. The IDS business realized reduced demand across all major product lines beginning in the third quarter of fiscal 2020 continuing through the second quarter of fiscal 2021, while the WPS business realized strong organic sales growth beginning in the fourth quarter of fiscal 2020 continuing through the first quarter of fiscal 2021 due to increased sales of personal protective equipment and other pandemic-related products. As a result, the recovery from the COVID-19 pandemic had a significant impact on organic sales during the first quarter of fiscal 2022, with the impact varying between the IDS and WPS businesses due to sales patterns realized during the height of the pandemic in fiscal 2021.

Gross margin increased 14.4% to $155.0 million in the three months ended October 31, 2021, compared to $135.4 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 48.2% compared to 48.9% in the same period in the prior year. The decrease in gross margin as a percentage of net sales was primarily due to an increase in the cost of materials, labor and freight expense, which was partially mitigated by our ongoing efforts to streamline manufacturing processes and drive sustainable operational efficiencies.

R&D expenses increased 36.3% to $13.9 million in the three months ended October 31, 2021, compared to $10.2 million in the same period in the prior year. As a percentage of sales, R&D expenses increased to 4.3% compared to 3.7% in the same period in the prior year. The increase in R&D spending was primarily due to the acquisitions of Code and Nordic ID, as these companies operate with a greater amount of R&D spend as a percentage of net sales compared to the organic business, in addition to an increase in R&D headcount in the IDS business. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers, materials, and the building out of a comprehensive industrial track and trace solution continue to be the primary focus of R&D expenditures for the remainder of fiscal 2022.

SG&A expenses include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses increased 16.5% to $96.7 million in the three months ended October 31, 2021, compared to $83.0 million in the same period in the prior year. The increase in SG&A expenses was primarily due to the acquisitions of Code, Magicard and Nordic ID, and to a lesser extent an increase in sales and marketing personnel in the IDS business and increased advertising and personnel costs in the WPS business. As a percentage of sales, SG&A was consistent at 30.1% for the three months ended October 31, 2021, compared to 30.0% in the same period in the prior year, as increased costs were largely offset by ongoing efficiency activities throughout SG&A.

Operating income increased 5.1% to $44.3 million in the three months ended October 31, 2021, compared to $42.2 million in the same period in the prior year. The increase in operating income was primarily due to the increase in segment profit in the IDS segment as a result of organic sales growth which was partially offset by the decline in segment profit in the WPS segment.

### OPERATING INCOME TO NET INCOME

*(Dollars in thousands)*

|  | Three months ended October 31, 2021 | % Sales | 2020 | % Sales |
| --- | ---: | ---: | ---: | ---: |
| Operating income | $44,335 | 13.8% | $42,188 | 15.2% |
| Other income (expense): |  |  |  |  |
| Investment and other income | 543 | 0.2% | 155 | 0.1% |
| Interest expense | (182) | (0.1)% | (106) | —% |
| Income before income tax and losses of unconsolidated affiliate | 44,696 | 13.9% | 42,237 | 15.2% |
| Income tax expense | 9,650 | 3.0% | 8,582 | 3.1% |
| Income before losses of unconsolidated affiliate | 35,046 | 10.9% | 33,655 | 12.1% |
| Equity in losses of unconsolidated affiliate | — | —% | (174) | (0.1)% |
| Net income | $35,046 | 10.9% | $33,481 | 12.1% |

Investment and other income increased to $0.5 million in the three months ended October 31, 2021, compared to $0.2 million for the same period in the prior year. The increase was primarily due to an increase in the market value of securities held in deferred compensation plans.

Interest expense increased to $0.2 million in the three months ended October 31, 2021, compared to $0.1 million for the same period in the prior year. The increase in interest expense was due to increased borrowing on our credit facility compared to the same period in the prior year.

The Company’s income tax rate was 21.6% for the three months ended October 31, 2021, compared to 20.3% in the same period in the prior year. Refer to Note M "Income Taxes" for additional information on the Company's income tax rate.

Equity in losses of unconsolidated affiliate of $0.2 million for the three months ended October 31, 2020 represented the Company's proportionate share of the loss in its equity interest in React Mobile, Inc., an employee safety software and hardware company based in the United States. In the fourth quarter of fiscal 2021, the Company recorded an other-than-temporary impairment charge for the Company's remaining equity interest in React Mobile, Inc.

#### Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, equity in losses of unconsolidated affiliate, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three months ended October 31, 2021 and 2020:

| SALES GROWTH INFORMATION ID Solutions | Three months ended October 31, 2021 | 2020 |
| --- | ---: | ---: |
| Organic | 13.2% | (8.4)% |
| Currency | 0.6% | 0.6% |
| Acquisitions | 11.6% | —% |
| Total | 25.4% | (7.8)% |
| **Workplace Safety** |  |  |
| Organic | (8.6)% | 5.5% |
| Currency | 0.8% | 4.3% |
| Total | (7.8)% | 9.8% |
| **Total Company** |  |  |
| Organic | 7.0% | (4.9)% |
| Currency | 0.7% | 1.5% |
| Acquisitions | 8.3% | —% |
| Total | 16.0% | (3.4)% |
| **SEGMENT PROFIT** |  |  |
| ID Solutions | $48,816 | $40,279 |
| Workplace Safety | 2,293 | 7,988 |
| Total | $51,109 | $48,267 |
| **SEGMENT PROFIT AS A PERCENT OF NET SALES** |  |  |
| ID Solutions | 19.6% | 20.3% |
| Workplace Safety | 3.1% | 10.1% |
| Total | 15.9% | 17.4% |

### ID Solutions

IDS net sales increased 25.4% to $248.6 million in the three months ended October 31, 2021, compared to $198.2 million in the same period in the prior year, which consisted of organic sales growth of 13.2%, sales growth from acquisitions of 11.6% and an increase from foreign currency translation of 0.6%. Organic sales grew in all major product lines with growth in the wire identification, safety and facility identification, product identification and healthcare identification product lines.

Organic sales in the Americas increased nearly 12%, organic sales in Europe increased in the mid-teens, and organic sales in Asia increased over 15% in the three months ended October 31, 2021 compared to the same period in the prior year. Organic sales grew in all major product lines and in all geographies as our businesses continue to recover from the economic slowdown caused by the COVID-19 pandemic.

Segment profit increased 21.2% to $48.8 million in the three months ended October 31, 2021, compared to $40.3 million in the same period in the prior year. As a percentage of net sales, segment profit was 19.6% compared to 20.3% in the same period in the prior year. The increase in segment profit was primarily due to increased sales volumes in all regions and all product lines globally. The decrease in segment profit as a percentage of net sales was primarily due to gross margin compression resulting from an increase in the cost of materials, labor and freight expense, as well as incremental amortization expense of $2.5 million from businesses acquired in fiscal 2021.

### Workplace Safety

WPS net sales declined 7.8% to $72.9 million in the three months ended October 31, 2021, compared to $79.0 million in the same period in the prior year, which consisted of an organic sales decline of 8.6% and an increase from foreign currency translation of 0.8%. The economic effect of the COVID-19 pandemic had a significant impact on organic sales trends during the prior year. The WPS business realized strong organic sales growth beginning in the fourth quarter of fiscal 2020 continuing through the first quarter of fiscal 2021 due to increased sales of personal protective equipment and other pandemic-related products. As a result, WPS organic sales declined in the first quarter of fiscal 2022 primarily due to the increase in sales of COVID-19 products during the height of the pandemic last year.

Organic sales in Europe declined in the high-single digits, organic sales in North America declined by approximately 12% and organic sales in Australia declined in the low-single digits in the three months ended October 31, 2021 compared to the same period in the prior year. The increase in demand for core safety and identification products did not make up for the decrease in demand for personal protective equipment and other social distancing signage and floor markings resulting from the COVID-19 pandemic. Digital channel sales and sales through the catalog channel both decreased in the high-single digits in the global WPS business.

Segment profit decreased 71.3% to $2.3 million in the three months ended October 31, 2021, compared to $8.0 million in the same period of the prior year. As a percentage of net sales, segment profit was 3.1% compared to 10.1% in the same period of the prior year. The decrease in segment profit was primarily due to the decrease in sales volumes and gross margin compression resulting from an increase in the cost of materials, labor and freight expense, as well as increased investments in advertising and selling resources in certain businesses in North America.

#### Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At October 31, 2021, approximately 94% of the Company's cash and cash equivalents were held outside the United States. The Company's organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

#### Cash Flows

Cash and cash equivalents were $157.6 million at October 31, 2021, an increase of $10.2 million from July 31, 2021. The following summarizes the cash flow statement for the three months ended October 31, 2021 and 2020:

*(Dollars in thousands)*

| Net cash flow provided by (used in): | Three months ended October 31, 2021 | 2020 |
| --- | ---: | ---: |
| Operating activities | $27,491 | $62,838 |
| Investing activities | (11,326) | (9,202) |
| Financing activities | (4,592) | (16,551) |
| Effect of exchange rate changes on cash | (1,355) | 1,605 |
| Net increase in cash and cash equivalents | $10,218 | $38,690 |

Net cash provided by operating activities was $27.5 million in the three months ended October 31, 2021, compared to $62.8 million in the same period of the prior year. The decrease was primarily due to cash outflows for inventory purchases in order to reduce the risk of supply chain disruption, and to a lesser extent an increase in accounts receivable due to increased sales during the quarter.

Net cash used in investing activities was $11.3 million in the three months ended October 31, 2021, compared to $9.2 million used in the same period of the prior year. The increase in cash used in investing activities was due to the purchase of two facilities in Europe which were previously leased.

Net cash used in financing activities was $4.6 million in the three months ended October 31, 2021, which consisted of dividend payments of $11.6 million and share repurchases of $18.9 million, partially offset by $29.0 million of net borrowing on the credit facility. Net cash used in financing activities of $16.6 million in the three months ended October 31, 2020 primarily consisted of dividend payments of $11.4 million, as well as share repurchases and tax withholding from stock-based awards of $5.3 million.

#### Credit Facilities

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks. Under this revolving loan agreement, the Company has the option to select either a Eurocurrency rate loan that bears interest at the London Inter-bank Offered Rate ("LIBOR") plus a margin based on the Company's consolidated net leverage ratio or a base interest rate (based upon the higher of the federal funds rate plus 0.5%, the prime rate of the Bank of Montreal plus a margin based on the Company’s consolidated net leverage ratio, or the

Eurocurrency base rate at the LIBOR rate plus a margin based on the Company’s consolidated net leverage ratio plus 1%). At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million.

As of October 31, 2021, the outstanding balance on the credit facility was $67.0 million which was also the maximum amount outstanding on the Company's revolving loan agreement during the three months ended October 31, 2021. The borrowings bear interest at 0.84% as of October 31, 2021. The Company had letters of credit outstanding under the loan agreement of $2.9 million as of October 31, 2021 and there was $130.1 million available for future borrowing, which can be increased to $330.1 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024. As such, borrowings were classified as long-term on the consolidated balance sheets.

#### Covenant Compliance

The Company's revolving loan agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of October 31, 2021, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the agreements, equal to 0.3 to 1.0 and the interest expense coverage ratio equal to 441.0 to 1.0.

#### Off-Balance Sheet Arrangements

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this and other Company filings. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

#### Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

- Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics
- Adverse impacts of vaccination mandates issued by U.S. and non-U.S. governmental entities
- Decreased demand for the Company's products
- Ability to compete effectively or to successfully execute its strategy
- Ability to develop technologically advanced products that meet customer demands
- Increased cost of raw materials, labor and freight as well as raw material shortages
- Ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses
- Difficulties in protecting websites, networks, and systems against security breaches
- Risks associated with the loss of key employees
- Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
- Litigation, including product liability claims
- Foreign currency fluctuations
- Potential write-offs of goodwill and other intangible assets
- Changes in tax legislation and tax rates
- Differing interests of voting and non-voting shareholders
- Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section set forth in this report and within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2021.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

## Market risk

As filed, 158 characters.

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2021. There has been no material change in this information since July 31, 2021.

## Controls and procedures

As filed, 1,802 characters.

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 2,054 characters.

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Brady's Annual Report on Form 10-K for the year ended July 31, 2021. Other than as set forth below, there have been no material changes from the risk factors set forth in the 2021 Form 10-K. The following risk factor is an additional risk within out "COVID-19 Risks" category.

***The U.S. Department of Labor's Occupational Safety and Health Administration ("OSHA") emergency temporary standard ("ETS") mandating either fully vaccination or weekly testing of employees could have a material adverse impact on our business and results of operations.***

On November 4, 2021, OSHA announced an ETS requiring that employers with 100 or more employees to implement and enforce a mandatory COVID-19 vaccination policy, unless they adopt a policy requiring employees to choose to either be vaccinated or undergo weekly COVID-19 testing and wear a face covering in the workplace. On November 5, 2021, the ETS was stayed by the U.S. Fifth Circuit Court of Appeals pending additional court review. Multiple other lawsuits were filed regarding the ETS in various jurisdictions. The pending lawsuits are expected to be consolidated before a federal circuit court, which circuit is then expected to rule on whether previous grants or denials of temporary stays will stand and to weigh in on the constitutionality of and other challenges to the ETS mandate. Additional vaccine mandates may be announced in jurisdictions in which our businesses operate. Our implementation of any such requirements if and when they are deemed to be enforceable may result in attrition, including attrition of critically skilled labor, and difficulty securing future labor needs, which could have a material adverse effect on our business and financial condition, and may result in costs of compliance that are difficult to quantify at this time and may also impact our financial condition.

Filed Nov 18, 2021.
Source: SEC EDGAR, the filing index for accession 0000746598-21-000198. Last ingested by Listed: Nov 9, 2026, 17:29 ET. No prices; not investment advice.
